Skip to content

The effect of intravenous flurbiprofen axetil on acute pain in patients undergoing CT-guided lung nodule puncture localization (a randomized controlled study)

The effect of intravenous flurbiprofen axetil on acute pain in patients undergoing CT-guided lung nodule puncture localization (a randomized controlled study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119457
Enrollment
Unknown
Registered
2026-02-27
Start date
2026-02-27
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung nodules require localization of the patient

Interventions

The conventional treatment group:Before patient positioning, a conventional local anesthesia method was used, where 2% lidocaine was applied for surface anesthesia.
Oral administration group:Sixty minutes before the patient positioning, the intervention of oral pregabalin capsules (75mg) + tramadol/acetaminophen tablets (37.5mg/325mg) was carried out.
Intravenous administration group:Before patient positioning, an intravenous injection of flurbiprofen axetil solution (50mg) was administered as an intervention 15 minutes prior.

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years old, with good cognitive and comprehension abilities; (2) American Society of Anesthesiologists (ASA) classification of grades I to III; (3) Signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Have severe neurological or mental disorders and epilepsy; (2) Be allergic to pregabalin and tramadol, acetaminophen, or flurbiprofen; (3) Have taken 5-hydroxytryptamine drugs (such as selective 5-hydroxytryptamine reuptake inhibitors and monoamine oxidase inhibitors) recently; (4) Regularly take other analgesics (such as opioid drugs); (5) Have a history of chronic chest pain; (6) Body Mass Index (BMI) >= 30 kg/m^2; (7) Unable to communicate normally, such as hearing impairment and language comprehension impairment; (8) Had severe cardiovascular or cerebrovascular diseases or liver and kidney dysfunction before the surgery; (9) Have severe respiratory diseases or obvious respiratory depression; (10) Have a history of lung surgery; (11) Other conditions that make one unsuitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
NRS pain score;

Secondary

MeasureTime frame
Recovery rate of analgesia;

Countries

China

Contacts

Public ContactZhao Gefei

The Affiliated Drum Tower Hospital of Nanjing University Medical School

zgf6160@sina.com+86 188 1301 9151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026